… of the coronavirus pandemic, as well as a bright post-pandemic outlook … augur well for more biotech mergers and acquisitions activity.
“Within the life … not take advantage of rising M&A activity.
“More than … 90% of life sciences M&A is for deals …
VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.